Protocol · Kidney Health
Renal Anemia (Anemia of Chronic Kidney Disease) Supportive Care Protocol
Iron and Vitamin D are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Renal Anemia (Anemia of Chronic Kidney Disease) Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| Iron | Amount listed: Oral: 100–200 mg elemental iron daily OR IV iron as prescribed (often preferred in CKD) | Essential for hemoglobin production; iron deficiency common in CKD and limits ESA response | Not graded yet | ||
| Vitamin D | Amount listed: Active vitamin D (calcitriol/paricalcitol) as prescribed OR cholecalciferol 1,000–2,000 IU daily | Supports erythropoietin responsiveness and bone health; deficiency universal in CKD | Not graded yet | ||
| Supporting stackListed as additions to the core | |||||
| Vitamin B12 | Amount listed: 1,000 mcg daily (if deficient) | Essential for red blood cell production; deficiency should be corrected | Not graded yet | ||
| Folate | Amount listed: 1–5 mg daily (higher doses in dialysis patients) | Required for red blood cell synthesis; may be depleted by dialysis | Not graded yet | ||
| Vitamin C | Amount listed: 200–500 mg daily (avoid high doses >500 mg in CKD due to oxalate) | Enhances iron absorption; may improve response to iron and ESA therapy | Not graded yet | ||
| L-Carnitine | Amount listed: 1–2 g daily or post-dialysis | May improve red blood cell membrane stability and reduce ESA requirements
| Grade D for Hematocrit1 study · 14 people | ||
| Omega-3 Fatty Acids | Amount listed: 1–2 g EPA+DHA daily | Anti-inflammatory; may support red blood cell membrane health | Not graded yet | ||
| Zinc | Amount listed: 15–30 mg daily | Often deficient in CKD; supports immune function and may help with taste | Not graded yet | ||
Shop this protocol
Support alongside medical care. These supplements are not a treatment for Renal Anemia (Anemia of Chronic Kidney Disease). If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
Each opens third-party tested products, matched to the dose above where we can.
- Grade D
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
How this protocol works
In plain language
Renal anemia, or anemia of chronic kidney disease (CKD), occurs because damaged kidneys produce less erythropoietin (EPO) - the hormone that signals the bone marrow to make red blood cells. This leads to low hemoglobin and symptoms including fatigue, weakness, shortness of breath, difficulty concentrating, and reduced exercise tolerance. Anemia typically appears when kidney function drops below 30-40% (CKD stage 3-4) and is almost universal in dialysis patients.
CRITICAL: Renal anemia requires management by a nephrologist. Primary treatment includes erythropoiesis-stimulating agents (ESAs like epoetin or darbepoetin) and iron supplementation - often given intravenously since oral iron is poorly absorbed in CKD. Target hemoglobin is typically 10-11.5 g/dL; higher targets increase cardiovascular risk. Iron status must be monitored (ferritin, transferrin saturation) before and during ESA therapy. These supplements support anemia treatment but do NOT replace ESAs when indicated. Untreated anemia increases cardiovascular risk and reduces quality of life.
Iron* is essential and often the first-line treatment. Iron deficiency is extremely common in CKD due to blood loss, reduced absorption, and inflammation. IV iron is often preferred as oral iron is poorly absorbed.
Vitamin D* deficiency is universal in CKD and affects EPO responsiveness. Both active vitamin D (requires prescription) and nutritional vitamin D supplementation may help.
Vitamin B12 and Folate* are required for red blood cell production. Deficiencies should be identified and corrected. Folate is especially important in dialysis patients as it's lost during treatment.
Vitamin C* enhances iron absorption and may improve response to iron therapy. However, high doses (>500mg) should be avoided in CKD due to oxalate accumulation.
L-Carnitine* may improve red blood cell survival and reduce ESA requirements in some dialysis patients.
Omega-3 Fatty Acids* have anti-inflammatory effects.
Zinc* is often deficient in CKD patients.
Expected timeline: Iron repletion takes 1-3 months. ESA response is seen within 2-4 weeks. Hemoglobin targets achieved over 2-4 months with proper therapy.